Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling

Gliptins vs. Milk-derived Dipeptidyl-Peptidase IV Inhibiting Biopeptides: Physicochemical Characterization and Pharmacokinetic Profiling

Background: Milk-derived biopeptides have reported in vitro dipeptidyl-peptidase IV (DPP-IV) inhibition, suggesting a glycemic-regulatory effect in Type 2 Diabetes Mellitus (T2DM). Nonetheless, the therapeutic application of these nutraceuticals is limited by the scarcity of knowledge regarding the...

Full description

Saved in:
Bibliographic Details
Main Authors: Jorge Andrés Barrero, Fabio Cabrera, Claudia Marcela Cruz
Format: article
Language:EN
Published: Universidad de Antioquia 2021
Subjects:
Bioactive peptides
Dipeptidyl-Peptidase IV inhibitors
Type 2 Diabetes Mellitus
Pharmacokinetics
Food processing and manufacture
TP368-456
Pharmaceutical industry
HD9665-9675
Online Access:https://doaj.org/article/b54a861ec7f74571ad98ecd6286ca34c
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/b54a861ec7f74571ad98ecd6286ca34c

Similar Items